AInvest★★★★★3-DAY FREE

Catch pre-market movers with AI signals.

Claim Trial
logo

CASI(Quitar la ciudad)

CASI Pharmaceuticals·NASDAQ
--
--(--)
3.84 / 10
Neutral

Fund-flow metrics are encouraging, scoring 6.67/10. Medium-sized inflows show a positive trend, hinting at underlying buying interest. Analyst coverage is limited to one ‘Strong Buy’ rating from HC Wainwright & Co., but the historical win rate for this analyst is only 0% over the recent 20 days, tempering enthusiasm. Sentiment is neutral, and overall capital movement is not yet decisively bullish.

FundamentalSentimiento(3.84)Técnico
Calificación de flujo de fondos
Calificación del analistaCompra fuerte

Opiniones de Wall Street

Compra fuerte

Compra fuerte

100%

Comprar

0%

Sostener

0%

Vender

0%

Venta fuerte

0%

Fecha2025-09-03
InstituciónHC Wainwright & Co.
Tiempos previstos3
Tasa histórica de ganancias0.0%